United States · FDA National Drug Code directory
PLUVICTO
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0078-1217_ade5aa80-b303-470f-8e79-7edea0c4a1bc
- Product NDC
- 0078-1217
- Form
- INJECTION, SOLUTION
- Composition / generic term
- lutetium Lu 177 vipivotide tetraxetan
- Labeler
- Novartis Pharmaceuticals Corporation
- Marketing category
- NDA
- Marketing start / end (source format)
- 20220323
- Source listing expiry
- 20271231
Source-listed ingredients
- LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN — 27 mCi/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL, GLASS in 1 PACKAGE (0078-1217-61) / 7.5 mL in 1 VIAL, GLASS · 0078-1217-61
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →